NLS Pharmaceutics AG (NLSP:NASDAQ) closed at $0.762 on October 30, 2025, up 2.97% on the day. The stock trades 98.2% below its 52-week high of $43.40 and 0.3% above its 52-week low of $0.760. NLS Pharmaceutics AG is part of the Health Care sector.
In 251 trading sessions since October 14, 2025, NLSP closed higher on 4 days (2%). Its best day was October 30, 2025 (+4.19%) and its worst was October 29, 2025 (-29.52%). The stock moved 10% or more in a single session 3 times.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. The company focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. The Company's lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD (Attention Deficit Hyperactivity Disorder).
Find more stocks like NLSP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.